AzTrials
AzTrials

Parenting InterventionRISENCT06669624

Resilience Through Interventions for Successful Early Outcomes

A study testing Attachment and Biobehavioral Catch-up (ABC) and Waitlist with 4-month delay, then ABC in people with Parenting Intervention and Stress, run by University of North Carolina, Chapel Hill at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Purpose: The purpose of this research is to determine the effects of Attachment and Biobehavioral Catch-up (ABC), an evidence-based parenting program, on stress biomarkers in children. Participants: The study will involve approximately 150 caregiver-child dyads, with children aged between 24 and 42 months. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Attachment and Biobehavioral Catch-up (ABC) and Waitlist with 4-month delay, then ABC
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteUnited States
Study dates
12 Nov 2024to Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Parent/Caregiver Inclusion Criteria :

  • Aged 18 or older
  • Speaks English or Spanish
  • Is the parent or legal guardian with legal custody of a child aged between 24 months and 42 months
  • Is a primary caregiver/parent
  • Has a home-like environment in which to participate in the intervention

Child Inclusion Criteria:

  • Aged between 24 months and 42 months at enrollment
  • Lives with the parent/caregiver at least 50% of the time
  • Has experienced social risk factors, including low income, community or family violence, previous trauma/adversity exposure, prolonged separation from caregiver, significant difficulties in relationship with caregiver Child Exclusion Criteria
  • Has a diagnosed genetic or congenital disorders, including but not limited to Down syndrome, cerebral palsy, seizure disorders, endocrine disorders (or is using steroid medications, including human growth hormone), or was born with birth defects

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Danielle Rouvinov, PhD contact

919-843-5898

roubinov@email.unc.edu

Nicole Bush, PhD contact

415-476-7655

Nicole.Bush@ucsf.edu

United States1 site, 1 recruiting
  • University of North Carolina at Chapel Hill

    Chapel Hill, South Carolina, 27599

    Natalie O'Brien, 919-966-0421, natalie_obrien@med.unc.edu

    Recruiting

Other trials in United States

About this study

Official title: Leveraging Scientific Advances to Strengthen the Implementation, Evaluation, and Impacts of Intervention Programs for Children Experiencing Early Life Adversity

Purpose: The purpose of this research is to determine the effects of Attachment and Biobehavioral Catch-up (ABC), an evidence-based parenting program, on stress biomarkers in children.

Participants: The study will involve approximately 150 caregiver-child dyads, with children aged between 24 and 42 months. Participants will include primary caregivers fluent in English or Spanish, along with their children who have experienced social risk factors for adversity.

Procedures (Methods): Participants will be randomly assigned to either receive the ABC parenting program (10 sessions) immediately or be placed on a wait-list, receiving the program after about 4 months. The study procedures include caregivers completing online surveys, engaging in play-based observational tasks with their children, and collecting non-invasive biological samples (saliva, cheek swab, hair) from the children and saliva samples from the caregivers at 2-3 time-points.

Being tested
Attachment and Biobehavioral Catch-up (ABC), Waitlist with 4-month delay, then ABC
Keywords
Attachment and Biobehavioral CatchUp, Parenting Intervention, RISE study, Child behavior, Biomarkers
Medical subject headings
Psychological Well-Being, Child Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Attachment and Biobehavioral Catch-up (ABC)Behavioural

    10-session home visiting intervention designed to increase parental sensitivity and nurturance and decrease parental frightening behavior.

  • Waitlist with 4-month delay, then ABCOther

    A 4-month waitlist period, after which they will also receive the home-based ABC program (same as Intervention group).

Study groups in NCT06669624
Study groupRoleWhat they receive
ABC Program - no waitExperimentalParticipants immediately receive the home-based ABC, which targets parenting sensitivity and nurturance.
Receives: Behavioral: Attachment and Biobehavioral Catch-up (ABC)
Waitlist-Control (ABC after delay)OtherParticipants will be placed on a four-month waitlist and then receive ABC in the same manner as the Experimental Group
Receives: Behavioral: Attachment and Biobehavioral Catch-up (ABC); Other: Waitlist with 4-month delay, then ABC

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Child inflammation

    Pediatric saliva samples will be assayed for cytokine concentrations.

    Measured: Pre-intervention baseline

  2. Child inflammation

    Pediatric saliva samples will be assayed for cytokine concentrations.

    Measured: 13-20 weeks after baseline

  3. Child epigenetic age acceleration

    Pediatric buccal swabs will be assayed for DNAm, which will be used to calculate child epigenetic age

    Measured: Pre-intervention baseline

  4. Child epigenetic age acceleration

    Pediatric buccal swabs will be assayed for DNAm, which will be used to calculate child epigenetic age

    Measured: 13-20 weeks after baseline

  5. Child telomere length

    DNA will be extracted from child buccal swabs to calculated T/S ratios.

    Measured: Pre-intervention baseline

  6. Child telomere length

    DNA will be extracted from child buccal swabs to calculated T/S ratios.

    Measured: 13-20 weeks after baseline

  7. Child hair cortisol

    Several strands of hair will be collected and assayed to obtain hair cortisol concentration

    Measured: Pre-intervention baseline

  8. Child hair cortisol

    Several strands of hair will be collected and assayed to obtain hair cortisol concentration

    Measured: 13-20 weeks after baseline

  9. Child stress hormones

    Child hair and saliva samples for cortisol, cortisone, DHEA, progesterone, and endocannabinoid levels to examine both cumulative and dynamic stress hormone responses.

    Measured: Pre-intervention baseline

  10. Child stress hormones

    Child hair and saliva samples for cortisol, cortisone, DHEA, progesterone, and endocannabinoid levels to examine both cumulative and dynamic stress hormone responses.

    Measured: 13-20 weeks after baseline

  11. Parenting

    Behavioral coding of parenting will be conducted using video recordings of tasks from the Early Regulation in Context Assessment.

    Measured: Pre-intervention baseline

  12. Parenting

    Behavioral coding of parenting will be conducted using video recordings of tasks from the Early Regulation in Context Assessment.

    Measured: 13-20 weeks after baseline

  13. Child wellbeing

    Caregiver reports of their child's quality of life will be obtained using the Pediatric Quality of Life (PedsQL) Inventory. Scores range from 0 to 100, with higher scores indicating better functioning.

    Measured: Pre-intervention baseline

  14. Child wellbeing

    Caregiver reports of their child's quality of life will be obtained using the Pediatric Quality of Life (PedsQL) Inventory. Scores range from 0 to 100, with higher scores indicating better functioning.

    Measured: 13-20 weeks after baseline

  15. Child executive functioning

    Child executive functioning will be assessed using the Minnesota Executive Function Scale™ The MEFS has been nationally normed based on the child's age and standardized scores are automatically generated using an algorithm that combines accuracy and response time (M = 100, SD = 15). Scores range from 60-140, with higher scores indicating better performance.

    Measured: Pre-intervention baseline

  16. Child executive functioning

    Child executive functioning will be assessed using the Minnesota Executive Function Scale™ The MEFS has been nationally normed based on the child's age and standardized scores are automatically generated using an algorithm that combines accuracy and response time (M = 100, SD = 15). Scores range from 60-140, with higher scores indicating better performance.

    Measured: 13-20 weeks after baseline

  17. Child mental health

    Child mental health will be assessed using caregiver reports through the Child Behavior Checklist preschool-aged form (1.5-5). We will use the total, internalizing, and externalizing subscales, with scores ranging from 0-200, 0-72, and 0-48, respectively. Higher scores represent worse functioning.

    Measured: Pre-intervention baseline

  18. Child mental health

    Child mental health will be assessed using caregiver reports through the Child Behavior Checklist preschool-aged form (1.5-5). We will use the total, internalizing, and externalizing subscales, with scores ranging from 0-200, 0-72, and 0-48, respectively. Higher scores represent worse functioning.

    Measured: 13-20 weeks after baseline

  19. Caregiver anxiety

    Caregiver anxiety symptoms will be assessed using the Generalized Anxiety Disorder 7-item (GAD-7) scale. The total score ranges from 0-21, with higher scores indicating more severe anxiety.

    Measured: Pre-intervention baseline

  20. Caregiver anxiety

    Caregiver anxiety symptoms will be assessed using the Generalized Anxiety Disorder 7-item (GAD-7) scale. The total score ranges from 0-21, with higher scores indicating more severe anxiety.

    Measured: 13-20 weeks after baseline

  21. Caregiver depression

    Caregiver depression symptoms will be assessed using the Patient Health Questionnaire-9 item form. Scores range from 0 to 27, with higher scores representing worse functioning.

    Measured: Pre-intervention baseline

  22. Caregiver depression

    Caregiver depression symptoms will be assessed using the Patient Health Questionnaire-9 item form. Scores range from 0 to 27, with higher scores representing worse functioning.

    Measured: 13-20 weeks after baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Nov 2024
  2. Study start12 Nov 2024
  3. Primary completionAug 2027 (estimated)
  4. Study completionAug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
RCT with a waitlist control group
Masking
Triple blind
Who is masked
Care provider, Investigator, Outcomes assessor
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06669624
Sponsor's protocol ID
24-0889
Acronym
RISE
Status last verified
Jan 2026
First submitted
28 Oct 2024
Last updated
2 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Deidentified individual data that supports the results, as well as derived data supporting the results.

Publications

  • McEwen LM, O'Donnell KJ, McGill MG, Edgar RD, Jones MJ, MacIsaac JL, Lin DTS, Ramadori K, Morin A, Gladish N, Garg E, Unternaehrer E, Pokhvisneva I, Karnani N, Kee MZL, Klengel T, Adler NE, Barr RG, Letourneau N, Giesbrecht GF, Reynolds JN, Czamara D, Armstrong JM, Essex MJ, de Weerth C, Beijers R, Tollenaar MS, Bradley B, Jovanovic T, Ressler KJ, Steiner M, Entringer S, Wadhwa PD, Buss C, Bush NR, Binder EB, Boyce WT, Meaney MJ, Horvath S, Kobor MS. The PedBE clock accurately estimates DNA methylation age in pediatric buccal cells. Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23329-23335. doi: 10.1073/pnas.1820843116. Epub 2019 Oct 14.

    PubMed 31611402
  • Sullivan ADW, Roubinov D, Norona-Zhou AN, Bush NR. Do dyadic interventions impact biomarkers of child health? A state-of-the-science narrative review. Psychoneuroendocrinology. 2024 Apr;162:106949. doi: 10.1016/j.psyneuen.2023.106949. Epub 2023 Dec 27.

    PubMed 38295654
  • Shonkoff JP, Boyce WT, Bush NR, Gunnar MR, Hensch TK, Levitt P, Meaney MJ, Nelson CA, Slopen N, Williams DR, Silveira PP. Translating the Biology of Adversity and Resilience Into New Measures for Pediatric Practice. Pediatrics. 2022 Jun 1;149(6):e2021054493. doi: 10.1542/peds.2021-054493.

    PubMed 35535547
  • Dozier M, Peloso E, Lewis E, Laurenceau JP, Levine S. Effects of an attachment-based intervention on the cortisol production of infants and toddlers in foster care. Dev Psychopathol. 2008 Summer;20(3):845-59. doi: 10.1017/S0954579408000400.

    PubMed 18606034
  • Dozier, M., Bernard, K., Roben, C. K., Steele, H., & Steele, M. (2017). Attachment and biobehavioral catch-up. Handbook of attachment-based interventions, 27-49.

  • de Mendonca Filho EJ, Pokhvisneva I, Maalouf CM, Parent C, Mliner SB, Slopen N, Williams DR, Bush NR, Boyce WT, Levitt P, Nelson CA, Gunnar MR, Meaney MJ, Shonkoff JP, Silveira PP; JPB Research Network on Toxic Stress. Linking specific biological signatures to different childhood adversities: findings from the HERO project. Pediatr Res. 2023 Aug;94(2):564-574. doi: 10.1038/s41390-022-02415-y. Epub 2023 Jan 17.

    PubMed 36650307

Questions about this trial

What is this clinical trial studying?

A study testing Attachment and Biobehavioral Catch-up (ABC) and Waitlist with 4-month delay, then ABC in people with Parenting Intervention and Stress, run by University of North Carolina, Chapel Hill at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Danielle Rouvinov, PhD (919-843-5898, roubinov@email.unc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Child inflammation (time frame: Pre-intervention baseline). The study lists 22 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06669624, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Feb 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in